Merck & Co. has halved its COVID-19 vaccine pipeline, saying it will end development of two candidates it co-developed with partners, saying they generated weaker immune responses than other unnamed COVID-19 vaccines—but will continue to develop two other vaccine candidates targeting SARS-CoV-2.
Insights into skeletal muscle ageing could help researchers explore ways to combat inflammation, boost muscle regeneration and preserve nerve connectivity
The past two years have seen exciting advances in the world of genomics, as several companies threaten to disrupt the next-gen sequencing (NGS) establishment. Meanwhile,…
Regeneron Pharmaceuticals shares have dipped 3% since the U.S. Department of Justice filed a complaint accusing the company of fraudulently reporting the price of Eylea®…
A new study finds genes are rewiring sensory nerves, which explains why existing drugs don’t work to alleviate pain for RA patients with limited synovial…
In this GEN webinar, our speakers will discuss how AI-based spatial analysis of mIF data can accelerate the discovery of clinically relevant biomarkers that can predict response…
RNA-targeting tools like Cas13d-NCS may open doors for precision medicine and proactive viral defense strategies.
In honor of National Robotics Week, we highlight some current applications of robotics and AI in the life sciences and what the future holds.
The next generation of predictive cancer biomarkers must move away from the reductionist view of biology and become more representative of the complex and functional…
AI-powered, functional precision medicine platform used to identify unique therapeutic treatment options in pediatric cancer.
Quanta Therapeutics is working on completing IND-enabling research on QTX3544 this year to support future clinical studies.
